S1P receptors on neuronal cells as a target of medicine for epilepsy
Project/Area Number |
24590112
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Biological pharmacy
|
Research Institution | Kobe University |
Principal Investigator |
OKADA Taro 神戸大学, 医学(系)研究科(研究院), 准教授 (80304088)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | スフィンゴシン1-リン酸 / スフィンゴ脂質 / スフィンゴシンキナーゼ / エクソソーム / スフィンゴシン1リン酸 |
Outline of Final Research Achievements |
Since it has recently been reported that alpha-synuclein (ASN) in cerebrospinal fluid is a biomarker of epilepsy, we investigated the effect of extracellular ASN on the neuronal cell functions. We found the extracellular ASN causes the inhibition of S1P1 receptor-Gi protein coupling. The ASN effect was subtype specific because it inhibits S1P1 as well as S1P3 receptors but doesn't inhibit S1P2-induced cell signaling. This finding is very important because it was already reported by our group that S1P receptor is involved in the neuronal functions. And this study also suggests the possibility of novel therapeutic strategy for treating epilepsy.
|
Report
(4 results)
Research Products
(7 results)
-
-
-
-
[Book] 細胞工学2015
Author(s)
梶本武利、岡田太郎、中村俊一
Total Pages
5
Publisher
秀潤社
Related Report
-
-
-